Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Linker

Showing results (21-30 of 359) with videos related to

Pageof 36
Sort By:
Therapeutic Advances in Chronic Disease|July 20, 2016
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapyRalf A Linker, Aiden Haghikia
Biochemistry|February 15, 1972
Purification of an unusual -glycuronidase from flavobacteriaC T Warnick, A Linker
Carbohydrate Research|March 1, 1976
Unusual properties of glycuronans (poly(glycosyluronic) compounds)A Linker, L R Evans
Drug Design, Development and Therapy|April 5, 2016
Laquinimod in the treatment of multiple sclerosis: a review of the data so farJan Thöne, Ralf A Linker
Journal of Neuroimmunology|October 17, 2008
Remote changes in gene expression after autoimmune demyelination: grey mattersRalf A Linker, Ralf Gold
Neurology and Therapy|September 15, 2016
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational StudyRalf A Linker, Guillaume Wendt
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
MBP-induced experimental autoimmune encephalomyelitis in C57BL/6 miceRalf A Linker, Ralf Gold
Current Neurology and Neuroscience Reports|September 25, 2013
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effectsRalf A Linker, Ralf Gold
Neurological Research and Practice|December 16, 2020
Navigating choice in multiple sclerosis managementRalf A Linker, Andrew Chan
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1987
Presence and role of glycosaminoglycans in amyloidosisA Linker, H C Carney
Pageof 36

Showing results (21-30 of 359) with videos related to

Sort By:
Pageof 36
Therapeutic Advances in Chronic Disease|July 20, 2016
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapyRalf A Linker, Aiden Haghikia
Biochemistry|February 15, 1972
Purification of an unusual -glycuronidase from flavobacteriaC T Warnick, A Linker
Carbohydrate Research|March 1, 1976
Unusual properties of glycuronans (poly(glycosyluronic) compounds)A Linker, L R Evans
Drug Design, Development and Therapy|April 5, 2016
Laquinimod in the treatment of multiple sclerosis: a review of the data so farJan Thöne, Ralf A Linker
Journal of Neuroimmunology|October 17, 2008
Remote changes in gene expression after autoimmune demyelination: grey mattersRalf A Linker, Ralf Gold
Neurology and Therapy|September 15, 2016
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational StudyRalf A Linker, Guillaume Wendt
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
MBP-induced experimental autoimmune encephalomyelitis in C57BL/6 miceRalf A Linker, Ralf Gold
Current Neurology and Neuroscience Reports|September 25, 2013
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effectsRalf A Linker, Ralf Gold
Neurological Research and Practice|December 16, 2020
Navigating choice in multiple sclerosis managementRalf A Linker, Andrew Chan
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1987
Presence and role of glycosaminoglycans in amyloidosisA Linker, H C Carney
Pageof 36